BEAM Conditioning Is Well Tolerated and Yields Similar Survival in Obese and Non-Obese Patients with Lymphoma: A Case Against Weight-Based Dose Modifications by Fair, Christina, PharmD, Rogosheske, John, PharmD, Shanley, Ryan, M.S, Bachanova, Veronika, MD, PhD

Get full text

Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT) by Bejanyan, Nelli, MD, Lazaryan, Aleksandr, MD MPH PhD, Shanley, Ryan, M.S, Patel, Sagar, M.D, Brunstein, Claudio, MD, PhD, Bachanova, Veronika, MD

Get full text

Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT) by Bachanova, Veronika, MD, Rogosheske, John, PharmD, Shanley, Ryan, M.S, Burns, Linda J., MD, Weisdorf, Daniel J., MD, Brunstein, Claudio, MD, PhD

Get full text

A Single Nucleotide Polymorphism in the Cytochrome p450 Gene Positively Impacts Survival Post Cyclophosphamide Conditioning in Autologous Transplants for Lymphoma by Bachanova, Veronika, MD, Shanley, Ryan, M.S, Burns, Linda J., MD, Lamba, Jatinder K., PhD, Chauhan, Lata

Get full text

Late Onset Acute GVHD (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) by Omer, Aazim, MD, Weisdorf, Daniel J., MD, Lazaryan, Aleksandr, MD MPH PhD, Shanley, Ryan, M.S, Blazar, Bruce R., MD, MacMillan, Margaret L., MD, MSc, Brunstein, Claudio, MD, PhD, Bejanyan, Nelli, MD, Arora, Mukta, MD, MS

Get full text